Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 4, 2005
Deregulation of collagen metabolism in human stomach cancerTomasz Guszczyn, Krzysztof Sobolewski
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 10, 2009
IGF-I and IGF-binding proteins in articular exudates of children with post-traumatic knee damage and juvenile idiopathic arthritisTomasz Guszczyn, Justyna Rzeczycka, Janusz Popko
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|April 12, 2014
[Congenital insensitivity to pain]Janusz Popko, Michał Karpiński, Tomasz Guszczyn
Journal of Clinical Medicine|October 16, 2024
Title Changes in Plasma Levels of Selected Matrix Metalloproteinases (MMPs) Enzymes in Patients with Osgood-Schlatter Disease (OSD)Monika Kulesza, Tomasz Guszczyn, Aleksandra Kicman, et al.
Ortopedia, Traumatologia, Rehabilitacja|May 13, 2022
Migration of Subtalar Implants in Paediatric Flatfoot Correction: A Pilot Study in Synthetic Bone ModelsMichał Kwiatkowski, Tomasz Guszczyn, Andrzej Sobolewski, et al.
Biochemical Society Transactions|January 27, 2011
Glycoconjugate markers of joint diseasesJanusz Popko, Sławomir Olszewski, Tomasz Guszczyn, et al.
International Journal of Molecular Sciences|December 23, 2023
Importance of Metalloproteinase Enzyme Group in Selected Skeletal System DiseasesMonika Kulesza, Aleksandra Kicman, Joanna Motyka, et al.
Journal of Clinical Medicine|July 27, 2024
The Effectiveness of Treating Osgood-Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the DiseaseTomasz Guszczyn, Monika Kulesza, Grzegorz Maciąg, et al.
Molecular and Cellular Probes|November 17, 2019
Verapamil and collagenase differentially affect collagen metabolism in experimental model of Peyronie's diseaseJacek Karaszewski, Ilona Zareba, Tomasz Guszczyn, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 18, 2023
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative TherapyTomasz Guszczyn, Monika Kulesza, Aleksandra Kicman, et al.
Pageof 3